Scientific Library
Reprogramming stem cells: a new innovative technology for the development of consistent and functional human cells
To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering.
Consistent, scalable human iPSC-derived glutamatergic neurons and skeletal myocytes
As detailed in a separate post, bit.bio have developed a novel cellular reprogramming technology, opti-ox™1 (optimized inducible overexpression), that can generate functional cells with high consistency
Advancing In Vivo Drug Delivery with Certest Smart Lipids & Smarter Targeting
Explore an insightful webinar where our partner Certest Pharma showcases the transformative potential of their ionizable lipids and capabilities for in vivo drug delivery.